Using this multi-omics approach, we confirmed that chemotherapy remodel the tumor microenvironment by increasing tumor infiltration by lymphocytes and showed that the addition of Pembrolizumab amplified these effects with signs of T cells reinvigoration and increased CD8+PD-1+ T cells in the vicinity of tumor cells. Here, CD8A is linked to neoplasm.